These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21747916)

  • 1. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
    Pan W; Issaq S; Zhang Y
    PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
    Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
    Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
    Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
    Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RP-Mdm2-p53 pathway and tumorigenesis.
    Miliani de Marval PL; Zhang Y
    Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
    Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.
    Dai MS; Challagundla KB; Sun XX; Palam LR; Zeng SX; Wek RC; Lu H
    J Biol Chem; 2012 May; 287(21):17120-17129. PubMed ID: 22467867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
    Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
    Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against High-Fat-Diet-Induced Obesity in MDM2
    Liu S; Kim TH; Franklin DA; Zhang Y
    Cell Rep; 2017 Jan; 18(4):1005-1018. PubMed ID: 28122227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein S2 interplays with MDM2 to induce p53.
    Cho J; Park J; Shin SC; Kim JH; Kim EE; Song EJ
    Biochem Biophys Res Commun; 2020 Mar; 523(2):542-547. PubMed ID: 31928715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.
    Liu Y; Deisenroth C; Zhang Y
    Trends Cancer; 2016 Apr; 2(4):191-204. PubMed ID: 28741571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
    Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
    EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
    Volk EL; Fan L; Schuster K; Rehg JE; Harris LC
    Mol Cancer Res; 2009 Jun; 7(6):863-9. PubMed ID: 19491200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
    Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
    PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
    Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
    Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
    Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
    J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.